Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide

BMJ Open

Volumn 6, Issue 2, 2016, Pages

  Nordling, Pauliina ^a   Kiviniemi, Tuomas ^a   Strandberg, Marjatta ^a   Strandberg, Niko ^a   Airaksinen, Juhani ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN T; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGE DISTRIBUTION; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PROGNOSIS; THORAX PAIN; VERY ELDERLY; BLOOD; ELECTROCARDIOGRAPHY; HIP FRACTURES; KAPLAN MEIER METHOD; MORTALITY; PROCEDURES; PROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; BIOMARKERS; ELECTROCARDIOGRAPHY; FEMALE; HIP FRACTURES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PERIOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; TROPONIN T;

EID: 84960403582     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-009416     Document Type: Article

References (20)

1. Hietala P, Strandberg M, Strandberg N, et al. Perioperative myocardial infarctions are common and often unrecognized in patients undergoing hip fracture surgery. J Trauma Acute Care Surg 2013;74:1087-91.
2. Cullen MW, Gullerud RE, Larson DR, et al. Impact of heart failure on hip fracture outcomes: a population-based study. J Hosp Med 2011;6:507-12.
3. Smeets SJ, Poeze M, Verbruggen JP. Preoperative cardiac evaluation of geriatric patients with hip fracture. Injury 2012;43:2146-51.
4. Ogawa Y, Nakao K, Mukoyama M, et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 1991;69:491-500.
5. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
6. Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997;47:287-96.
7. Chong CP, Ryan JE, Van Gaal WJ, et al. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery. Am J Cardiol 2010;106:865-72.
8. Oscarsson A, Fredrikson M, Sörliden M, et al. N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery. Br J Anaesth 2009;103:206-12.
9. Yun KH, Jeong MH, Oh SK, et al. Preoperative plasma N-terminal pro-brain natriuretic peptide concentration and perioperative cardiovascular risk in elderly patients. Circ J 2008;72:195-9.
10. Oscarsson A, Fredrikson M, Sörliden M, et al. Predictors of cardiac events in high-risk patients undergoing emergency surgery. Acta Anaesthesiol Scand 2009;53:986-94.
11. Schutt RC, Cevik C, Phy MP. Plasma N-terminal prohormone brain natriuretic peptide as a marker for postoperative cardiac events in high-risk patients undergoing noncardiac surgery. Am J Cardiol 2009;104:137-40.
12. Dernellis J, Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 2006;92:1645-50.
13. Villacorta Junior H, Castro IS, Godinho M, et al. B-type natriuretic peptide is predictive of postoperative events in orthopedic surgery. Arq Bras Cardiol 2010;95:743-8.
14. Yeh HM, Lau HP, Lin JM, et al. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg 2005;92:1041-5.
15. Hietala P, Strandberg M, Kiviniemi T, et al. Usefulness of troponin T to predict short-term and long-term mortality in patients after hip fracture. Am J Cardiol 2014;114:193-7.
16. Airaksinen KE, Korkeila P, Lund J, et al. Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment-the FinPAC study. Int J Cardiol 2013;168:3679-82.
17. Airaksinen KE, Grönberg T, Nuotio I, et al. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study. J Am Coll Cardiol 2013;62:1187-92.
18. Kiviniemi T, Puurunen M, Schlitt A, et al. Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol 2014;113:1995-2001.
19. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9.
20. Chong CP, Lim WK, Velkoska E, et al. N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery. Am J Cardiol 2012;109:1365-73.